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*P < 0.05, **P < 0.01 d. to baseline, @P < 005 Group 1vs. Group 2
Group 2 pts had depressed microvascular and ECA dilation with ACH com-
pared to Group 1 pts (Table). In contrast, with SP, microvascular dilation was
similar in both groups, and ECA dilation was higher in those without RF; how-
ever, the correlation between the magnitude of ECA dilation with ACH and
SP was weak (r = 0.21). Thus, there is a preponderance of muscarinic recep-
tors in the microvessels, whereas SP receptors are located predominantly in
human ECA. In pts with RF and atherosclerosis, ACH-induced endothelium-
dependent ECA and microvascular dilation is depressed, but microvascu-
lar dilation with SP appears unaffected and SP-induced ECA dilation is only
mildly reduced. Therefore, atherosclerosis and its RF appearto produce non-
uniform dysfunction of various endothelial cell surface receptors in the hu-
man coronary vasculature.
Effects of NPC 15669 on Myocardial Stunning
and Infarction Size
Victor L. Serebruany, Matthew L. Schlossberg, Paul A. Gurbel, Robert A. Vogel,
William R. Herzog. University ofMaryland, Baltimore, MD
impaired (I = ejection fraction <40%) LV-function, 17 pts in Nand 7 pts in I
received atropine before ischemia was induced by incremental atrial pacing.
Placebo was administered to a matching control group (CN and CI, resp.). All
pts had>70% left CAD. During maximal pacing, heart rate and rate pressure
product (myocardial oxygen demand) where 7% and 12% higher in N, com-
pared to CN, but were comparable in I and CI. Moreover, 1 minute post pac-
ing these values were 8% and 12% higher, resp., N vs CN. Vasoconstrictive
circulating neurohormones (norepinephrine) increased similarly in all groups.
Coronary flow increased 23% more in N than in CN and to a similar extent
in I and CI. Myocardial ischemia, as indicated by changes in myocardiallac-
tate metabolism, was less in N [lactate extraction +10% (N) vs -21 % (CN),
-18% (I) and -19% (CI)]. Fifteen minutes after pacing, coronary flow was
still decreased by 11 % and coronary vascular resistance increased by 15%
in CN, as compared to N. Thus, reduction of parasympathetic tone improves
coronary flow and reduces myocardial ischemia in the latter, despite similar
sympathetic activation and more pronounced myocardial oxygen demand in
N. This supports a greater role for cardiovascular parasympathetic control of
(diseasedl coronary arterial system in normal LV-function and, possibly, a new
area of intervention in anti ischemic therapy in the latter.
Correlation Between Magnesium Deficiency and
Disease ActiVity in Patients with Variant Angina
and the Effect of Oral Magnesium
Supplementation
Kazuo Satake, Jong-Dae Lee, Hiromasa Shimizu, Hiroyasu Uzui, Norio Kawasaki,
Akiyosi Tsubokawa, Taeko Sugiyama, Takanori Ueda, Toru Nakamura. The First
Department of Internal Medicine, Fukui Medical School, Fukui, Japan
Purpose; We examined whether or not the degree of intracellular magnesium
(Mg) deficiency correlates with disease activity of variant angina (VA) and the
effect of oral Mg supplementation. Methods; Eighteen patients with VA (17
men and a woman) were divided into 2 groups according to the frequency of
occurrence of angina attacks (inactive and active group> 3 angina attacks
per week).
We measured Mg status by serum, urinary excretion, 24-hour Mg reten-
tion rate. Intracellular Mg content of mononuclear cell (MNC) and erythrocyte
were also measured by atomic absorption spectrophotometry We also ex-
amined the effect of oral Mg supplementation (Mg oxide 0.6 g/day, more
than 2 months) to refractory patients (n = 4) with Mg deficiency. Result; There
were no significant differences in serum Mg content between active and in-
active groups. Urinary Mg excretion in a day in active group (136.4 ± 36.6
mg/dat) was significantly higher than in inactive group (59.1 ± 7.0; P < 0.05).
Retention rate and intracellular Mg content of MNC and erythrocyte were
57.0 ± 7.3 vs 24.7 ± 3.2% (p < 0.01), 151.3 ± 14.4 vs 214.3 ± 8.0 fg/cell (p <
0.01) and 3.8 ± 0.5 vS 5.1 ± 0.4 fg/cell (p < 0.05). respectively. Retention rate
and intracellular Mg content of MNC and erythrocyte correlated well with the
frequency of angina attacks in these patients (r = 0.78, p < 0.01: r = 0.76, P
< 0.01 : r = -0.50, p < 0.05). With oral Mg supplementation, the response to
calcium antagonist was improved, coupled with the increase of intracellular
Mg content, from 151 ± 19.8 to 226.8 ± 17.0 fglcell in MNC and from 3.0 ±
0.6 to 5.0 ± 0.3 fg/cell in erythrocyte.
Conclusion; It is concluded that the degree of intracellular Mg deficiency
correlates well with disease activity of VA, suggesting that Mg deficiency
plays an important role in accelerating disease activity. Oral Mg supplemen-
tation appears to be an effective and less expensive regimen for patients with
VA.
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To investigate whether atherosclerosis and its risk factors (RF) that are known
to result in abnormal coronary vasodilator responses to muscarinic receptor
stimulation with acetylcholine{ACH), are also associated with generalized en-
dothelial receptor dysfunction, we compared the effects of substance P(SP)
with those of ACH in the human coronary vasculature. In 25 patients, 7 (Group
1) with normal coronary arteries and no RF. and 18 (Group 2) with either RF
for, orestablished atherosclerosis (>20% stenosis), intracoronaryACH (3, 30,
100, 300 fLg/min) and SP (5, 10, 20 pmollmin) were given. Coronary blood
flow was measured using a Doppler flow wire and epicardial coronary artery
(ECA) diameter by quantitative angiography. Results; Microvascular dilation
measured as a decrease in coronary vascular resistance (CVR) with ACH was
greater compared to SP (-49 ± 23% vs. -24 ± 19% respectively, p < 0.01),
but ECA dilation with SP was greater compared to ACH (0 ± 14% (ACH) vs.
16±17%SP,p<0.01).
istered to determine the influence of ISO on endothelial dependent and inde-
pendent vasodilatation. In the control state (*p < 0.05). both IC-ACh and IC-
SNP resulted in marked coronary vasodilatation (ll. CBF ACh 76 ± 6* mllmin
and SNP 37 ± 7*) while IC-ANP did not alter CBF. IC-ISO increased basal
CBF (52 ± 11 ml/min to 87 ± 21*) and LV contractility (+dP/dt 1803 ± 93
mmHgL/sec to 2395 ± 151*). and decreased coronary vascular resistance
(CVR 2.6 ± 0.3 RU to 1.4 ± 0.2*) and coronary perfusion pressure (105 ±
7 mmHg to 87 ± 7*). In the presence of ISO, IC-ANP significantly increased
CBF (87 ± 21 ml/min to 117 ± 26*) while ACh and SNP-mediated coronary
vasodilation were similar to control changes.
In summary, IC-ISO augments ANP-mediated coronary vasodilatation but
does not enhance ACh or SNP mediated vasodilatation. This observation
suggests a functional link between the natriuretic peptide system and the
II-adrenergic system in the control of CBF. The elevation in circulating cat-
echolamines observed in CH F may, therefore, serve in part to augment en-
dogenous ANP-mediated coronary vasodilation and thus be coronary protec-
tive in the progression of CHF.
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Anti-Ischemic Agents and Mechanisms
Ad FM. van den Heuvel, Martin van der Ent, Willem J. Remme. Sticares Foundation,
Rotterdam, The Netherlands
Cardiovascular parasympathetic control reportedly is reduced in left ventricu-
lar (LV) dysfunction and in heart-failure. To evaluate whether parasympathetic
intervention differentially affects coronary flow and ischemia in normal (N) vs
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Leukocytes have been implicated in myocardial infarction (MI) development
and progression. We tested the efficacy of the novel leukocyte recruitment in-
hibitor NPC 15669 (Scios Nova, Inc.) on myocardial stunning (MS) and precon-
ditioned MI. NPC is a member of the leumedins, and is an inhibitor of leuko-
cyte adhesion to endothelium via blockage of integrin binding. We also show,
that NPC 15669 have strong antiplatelet effects. In an open chested swine
model, NPC 15669 (10 mg NPC/kg loading dose followed by constant infu-
sion at 6 mg/kg-1/h-l )was administered in 6 animals. Myocardial thickening
(MT) was determined by epicardial ultrasound. The left anterior descending
artery was occluded for 8 min. followed by 90 min. of reperfusion, during
which myocardial MT was recorded at regular intervals. We have found that
treatment with NPC 15669 increases myocardial contractility and significantly
decreases MS time compared to six controls (26.7 ± 4.0 min vs. 50.0 ± 4.3
min, p = 0.0026). This report also demonstrates the beneficial effects of NPC
15669 on myocardial tissue survival after a period of ischemia. In NPC 15669
treated animals 23.4 ± 6.7% of at risk tissue became necrotic compared to
53.0 ± 6.6% in controls, p = 0.0102. Our data suggests that NPC 15669 sig-
nificantly reduces myocardial injury in both the stunning and infarction mod-
Parasympathetic Intervention Affects Ischemia
by Increasing Coronary Flow in Normal, but not
in Impaired Left Ventricular Function. A New
Approach to Antilschemic Therapy?
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